Medical Devices
Peripherally Inserted Central Catheters Market

Peripherally Inserted Central Catheters Market Size, Trends, Share, Growth, and Regional Forecast, 2026 to 2033

Peripherally Inserted Central Catheters Market by Product (Power Injected Peripherally Inserted Central Catheters, Conventional Peripherally Inserted Central Catheters), Design (Single Lumen, Double Lumen, Multiple Lumen), End-user (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories, Others) and Regional Analysis from 2026 to 2033

ID: PMRREP12316

December 2025

199 Pages

Author : Abhijeet Surwase

Healthcare

Key Industry Highlights

Dominant Segment: Conventional PICCs lead the 2025 market with 63.3% share, driven by broad adoption in hospitals, cost-effectiveness, ease of insertion, long-term infusion use, and established clinical protocols for chemotherapy, parenteral nutrition, and antibiotic therapies. Power-injectable PICCs follow, gaining traction in advanced imaging and high-pressure infusion applications.
Dominant Region: North America holds 38.7% share due to advanced hospital infrastructure, skilled workforce, established reimbursement systems, and high adoption of PICC devices. Europe follows closely, while Asia Pacific grows fastest, supported by expanding healthcare access, rising chronic disease burden, increasing use of oncology treatments, and growing local adoption of PICC devices.
Market Drivers: Growth is fueled by the rising prevalence of chronic diseases and cancer, increasing demand for long-term IV therapies, expanding outpatient and home healthcare, growing awareness of PICC benefits, technological advancements in catheter materials and tip-placement guidance, and adoption of power-injectable and multi-lumen devices.
Market Opportunity: Key opportunities include expanding power-injectable and multi-lumen PICCs, developing antimicrobial or coated catheters, growing home-infusion and outpatient care, cost-effective device production, strategic collaborations for innovative catheter designs, and increasing adoption in emerging markets with growing healthcare infrastructure and trained personnel.

Key Insights	Details
Peripherally Inserted Central Catheters Market Size (2026E)	US$ 2.3 Bn
Market Value Forecast (2033F)	US$ 4.1 Bn
Projected Growth (CAGR 2026 to 2033)	8.3%
Historical Market Growth (CAGR 2020 to 2025)	7.1%

peripherally-inserted-central-catheters-market-2026–2033

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Growth of Chemotherapy & Parenteral Nutrition

The growing use of chemotherapy and parenteral nutrition (PN) is a major driver of the PICC market because both therapies require reliable, long-term venous access. Global cancer incidence continues to rise, with countries like India reporting over 1.4 million new cancer cases in 2022, contributing to a large population needing multi-cycle chemotherapy.

A clinical study evaluating long-term home PN in cancer patients reported more than 55,000 catheter-days of PICC use, with 71% of these patients receiving chemotherapy alongside nutritional support. The same study reported strong safety outcomes, including a catheter-related bloodstream infection rate of 0.05 per 1,000 catheter-days and symptomatic thrombosis in only about 1% of cases, demonstrating PICC reliability for prolonged home infusion therapy.

As chemotherapy protocols become more intensive and treatment-induced malnutrition increases PN demand, PICCs remain the preferred vascular access option, collectively boosting market growth through expanding oncology and nutritional support needs.

Restraints - Risk of Complications (DVT, Infection, Occlusion)

Complication risks such as deep vein thrombosis (DVT), catheter-related bloodstream infections, and occlusions significantly restrain PICC market growth because they affect patient safety and clinical preference. A large nine-year study reported that 28.1% of PICC insertions experienced some form of complication, equal to nearly 5 events per 1,000 catheter-days, with thrombosis accounting for about 10.9% and catheter-associated infections approximately 7.5%.

Broader clinical reviews show complication rates ranging from 9.5% to 38.6%, with venous thrombosis occurring in 2.3-5.9% of patients and catheter-related infections in 1.4-1.9%. In intensive care settings, symptomatic DVT rates have reached 4.6 per 1,000 catheter-days.

These events often require catheter removal, treatment interruption, additional imaging, anticoagulation therapy, or replacement with alternative vascular access devices. As hospitals and clinicians prioritize safety and lower complication profiles, concerns about thrombosis, infection, and occlusion reduce the preference for PICCs in certain patient groups, posing a significant restraint on market expansion.

Opportunity - Growth of Home-Infusion & Outpatient Care

The rise of home-infusion and outpatient care presents a major opportunity for the PICC market, driven by the global shift toward safer, cost-efficient alternatives to hospital-based therapy. In the U.S., more than 3.2 million patients receive home-infusion therapy each year, and PICC lines are used in nearly two-thirds of all vascular access devices placed in home-care settings.

This high utilization reflects PICC suitability for long-term antibiotics, chemotherapy, hydration, and parenteral nutrition outside the hospital. Health systems increasingly encourage outpatient IV therapy because it can reduce inpatient costs by 30-60% and lower hospital-acquired infection rates by moving patients out of high-risk environments.

Growing burdens of chronic infections, cancer, and gastrointestinal conditions also increase the need for long-duration infusions that can be safely managed at home. As more countries expand home-health programs and adopt outpatient IV protocols, demand for reliable central access devices, such as PICCs, continues to rise, creating a strong growth opportunity.

Category-wise Analysis

By Product Insights

Conventional peripherally inserted central catheters occupy 63.3% of the global market in 2025 because they are simpler, more cost-effective, and suitable for most infusion therapies compared with power-injectable or multi-lumen catheters. Studies show that increasing the use of single-lumen PICCs can prevent about one deep-vein thrombosis and one catheter-related bloodstream infection per 1,000 catheters annually, highlighting their safety advantage.

Most home-infusion and non-critical care patients do not require high-pressure injection or multiple simultaneous infusions, making conventional PICCs sufficient for routine antibiotics, chemotherapy, or parenteral nutrition. Their lower cost, ease of maintenance, and reduced risk of complications make them the preferred choice for hospitals and outpatient settings.

Consequently, conventional PICCs continue to account for the majority of PICC insertions, reinforcing their dominant position in the global market.

By Design Insights

Multiple-lumen PICCs dominate the market because they allow simultaneous infusion of incompatible therapies without repeated venous access. Their design is particularly valuable for patients requiring complex treatments, such as chemotherapy, total parenteral nutrition, antibiotics, and blood transfusions.

Hospitals and clinicians prefer multi-lumen devices for intensive care, oncology, and long-term therapy because they reduce the need for multiple line insertions, improving patient comfort and workflow efficiency. The growing prevalence of chronic illnesses, cancer, and ICU admissions further drives demand. Despite slightly higher risks of infection and thrombosis compared to single-lumen PICCs, their versatility makes them the preferred choice in modern healthcare settings.

peripherally-inserted-central-catheters-market-outlook-by-product-2026–2033

Request Free sampleRequest Free sample

Regional Insights

North America Peripherally Inserted Central Catheters Market Trends

North America, especially the U.S., benefits from a mature, advanced healthcare system with thousands of hospitals and widespread adoption of minimally invasive treatments. Each year the U.S. alone performs over 2.7 million PICC insertions, reflecting high procedural volume and clinician comfort.

The region also has a substantial burden of chronic diseases, cancer, and a growing elderly population, driving demand for long-term IV access in oncology, intensive care and home infusion settings. Generous reimbursement policies, well-staffed vascular-access teams, and strong institutional infrastructure (hospital beds, outpatient infusion centers) further support broad adoption. That combination of infrastructure, disease burden and clinical preference keeps North America at the top globally.

Europe Peripherally Inserted Central Catheters Market Trends

Europe is a key region for the peripherally inserted central catheters market due to its ageing population, strong hospital infrastructure, and high demand for safe intravenous therapies. In 2024, over 21% of the European Union population was aged 65 or older, a group frequently requiring long-term or repeated IV treatments such as chemotherapy, antibiotics, nutrition, or hydration.

Many European hospitals report that 80-90% of inpatients receive IV therapy, highlighting the extensive need for reliable venous access. Strong regulatory standards, strict infection-control practices, and universal healthcare coverage further support PICC adoption over repeated peripheral cannulations. These demographic, clinical, and regulatory factors together make Europe an important and growing market for PICCs.

Asia Pacific Peripherally Inserted Central Catheters Market Trends

The Asia Pacific region is the fastest-growing market for peripherally inserted central catheters due to rapid demographic changes and rising healthcare needs. In 2024, the area had approximately 503 million people aged 65 and above, representing 10.5% of the population, projected to nearly double to 996 million, or 19.3%, by 2050.

This ageing population drives higher demand for long-term intravenous therapies, including chemotherapy, nutrition, antibiotics, and critical care treatments. Additionally, the Asia Pacific is witnessing significant expansion in healthcare infrastructure, with more hospital beds, infusion centers, and advanced medical facilities being developed.

Increasing healthcare spending, growing awareness of minimally invasive treatments, and rising prevalence of chronic and cancer-related conditions are further accelerating PICC adoption, making the Asia Pacific the fastest-growing regional market.

peripherally-inserted-central-catheters-market-outlook-by-region-2026-2033

Competitive Landscape

Leading companies in the peripherally inserted central catheters market focus on high-quality catheter design, multi-lumen innovations, and strict safety standards. They invest in research, training, and advanced materials, collaborating with hospitals and healthcare providers to improve efficacy, reduce complications, and expand adoption globally, supporting the growing demand for long-term intravenous therapies.

Key Industry Developments:

In October 2025, BD India launched the Sherlock 3CG+ system to improve the efficiency of PICC line placement. The new technology enabled clinicians to perform precise, real-time catheter navigation, reducing procedure time and enhancing patient safety, while supporting hospitals in delivering more accurate and streamlined intravenous therapy.
In September 2024, B. Braun Medical received FDA clearance for its Introcan Safety® 2 Deep Access IV Catheter. The approval allowed the company to market this advanced IV catheter in the U.S., offering improved safety features and ease of use for healthcare providers, while enhancing patient care during intravenous therapy procedures
In February 2024, AngioDynamics sold its PICC and midline product portfolios to Spectrum Vascular for $45 million. The transaction transferred ownership of these catheter lines, enabling Spectrum Vascular to expand its vascular access offerings, while AngioDynamics focused on its core business areas.

Companies Covered in Peripherally Inserted Central Catheters Market

AngioDynamic, Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
C. R. Bard, Inc.
Teleflex Incorporated
Argon Medical Devices, Inc.
Boston Scientific Corporation
COOK MEDICAL INC.
ICU Medical Inc.
Medical Components, Inc.
Medtronic, Inc
Navilyst Medical, Inc.
Vygon (UK) Ltd
Others

Frequently Asked Questions

The global peripherally inserted central catheters market is projected to be valued at US$ 2.3 billion in 2026.

Rising chronic diseases, cancer cases, ageing population, ICU expansion, and preference for long-term, minimally invasive intravenous therapies drive the global PICC market.

The global peripherally inserted central catheters market is poised to witness a CAGR of 8.3% between 2026 and 2033.

Growing home healthcare, rising outpatient treatments, advanced multi-lumen catheters, emerging Asia Pacific demand, and increasing awareness of minimally invasive IV therapies.

AngioDynamic, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, C. R. Bard, Inc., Teleflex Incorporated, Argon Medical Devices, Inc.

Report Attribute	Details
Historical Data/Actuals	2020 - 2025
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Bn
Geographical Coverage	North America Europe East Asia South Asia & Oceania Latin America Middle East and Africa
Segmental Coverage	Product Design End-user Region
Competitive Analysis	AngioDynamic, Inc. B. Braun Melsungen AG Becton, Dickinson and Company C. R. Bard, Inc. Teleflex Incorporated Argon Medical Devices, Inc. Boston Scientific Corporation COOK MEDICAL INC. ICU Medical Inc. Medical Components, Inc. Medtronic, Inc Navilyst Medical, Inc. Vygon (UK) Ltd Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Peripherally Inserted Central Catheters Market Size (2026E)

US$ 2.3 Bn

Market Value Forecast (2033F)

US$ 4.1 Bn

Projected Growth (CAGR 2026 to 2033)

8.3%

Historical Market Growth (CAGR 2020 to 2025)

7.1%

Report Attribute	Details
Historical Data/Actuals	2020 - 2025
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Bn
Geographical Coverage	North America Europe East Asia South Asia & Oceania Latin America Middle East and Africa
Segmental Coverage	Product Design End-user Region
Competitive Analysis	AngioDynamic, Inc. B. Braun Melsungen AG Becton, Dickinson and Company C. R. Bard, Inc. Teleflex Incorporated Argon Medical Devices, Inc. Boston Scientific Corporation COOK MEDICAL INC. ICU Medical Inc. Medical Components, Inc. Medtronic, Inc Navilyst Medical, Inc. Vygon (UK) Ltd Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools

Executive Summary
1. Global Peripherally Inserted Central Catheters Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Regulatory Landscape
2. Product Adoption Analysis
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
3. Global Peripherally Inserted Central Catheters Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Product, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
    1. Power Injected Peripherally Inserted Central Catheters
    2. Conventional Peripherally Inserted Central Catheters
  4. Market Attractiveness Analysis: Product
4. Global Peripherally Inserted Central Catheters Market Outlook: Design
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Design, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
    1. Single Lumen
    2. Double Lumen
    3. Multiple Lumen
  4. Market Attractiveness Analysis: Design
5. Global Peripherally Inserted Central Catheters Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Catheterization Laboratories
    4. Others
  4. Market Attractiveness Analysis: End User
Global Peripherally Inserted Central Catheters Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Design
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
  1. Power Injected Peripherally Inserted Central Catheters
  2. Conventional Peripherally Inserted Central Catheters
5. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
  1. Single Lumen
  2. Double Lumen
  3. Multiple Lumen
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Catheterization Laboratories
  4. Others
7. Market Attractiveness Analysis
Europe Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Design
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
  1. Power Injected Peripherally Inserted Central Catheters
  2. Conventional Peripherally Inserted Central Catheters
5. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
  1. Single Lumen
  2. Double Lumen
  3. Multiple Lumen
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Catheterization Laboratories
  4. Others
7. Market Attractiveness Analysis
East Asia Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Design
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
  1. Power Injected Peripherally Inserted Central Catheters
  2. Conventional Peripherally Inserted Central Catheters
5. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
  1. Single Lumen
  2. Double Lumen
  3. Multiple Lumen
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Catheterization Laboratories
  4. Others
7. Market Attractiveness Analysis
South Asia & Oceania Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Design
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
  1. Power Injected Peripherally Inserted Central Catheters
  2. Conventional Peripherally Inserted Central Catheters
5. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
  1. Single Lumen
  2. Double Lumen
  3. Multiple Lumen
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Catheterization Laboratories
  4. Others
7. Market Attractiveness Analysis
Latin America Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Design
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
  1. Power Injected Peripherally Inserted Central Catheters
  2. Conventional Peripherally Inserted Central Catheters
5. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
  1. Single Lumen
  2. Double Lumen
  3. Multiple Lumen
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Catheterization Laboratories
  4. Others
7. Market Attractiveness Analysis
Middle East & Africa Peripherally Inserted Central Catheters Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Design
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 - 2033
  1. Power Injected Peripherally Inserted Central Catheters
  2. Conventional Peripherally Inserted Central Catheters
5. Market Size (US$ Bn) Analysis and Forecast, By Design, 2026 - 2033
  1. Single Lumen
  2. Double Lumen
  3. Multiple Lumen
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Catheterization Laboratories
  4. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. AngioDynamic, Inc.
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. B. Braun Melsungen AG
  3. Becton, Dickinson and Company
  4. C. R. Bard, Inc.
  5. Teleflex Incorporated
  6. Argon Medical Devices, Inc.
  7. Boston Scientific Corporation
  8. COOK MEDICAL INC.
  9. ICU Medical Inc.
  10. Medical Components, Inc.
  11. Medtronic, Inc
  12. Navilyst Medical, Inc.
  13. Vygon (UK) Ltd
  14. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Peripherally Inserted Central Catheters Market Size, Trends, Share, Growth, and Regional Forecast, 2026 to 2033